Cofrogliptin Once Every 2 Weeks as Add-on Therapy to Metformin and Dapagliflozin Versus Daily Linagliptin in Patients With Type 2 Diabetes.

Abroad (travel likely)RecruitingPHASE4

Conditions

T2DM

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations
  • Wuhan University People's Hospital, Wuhan, Hubei, China

    Contact: Study coordinator (Zhelong Liu, Doctor) · liuzhelong@163.com · +86 139 8623 5028
    Contact: Principal Investigator (Xuefeng Yu, Doctor)
  • Wuhan University People's Hospital, Wuhan, Hubei, China

    Contact: Study coordinator (Lin Gao, Doctor) · rmyyrcb@163.com · +86-27-88041911
Study leads
  • XueFeng Yu, Doctor

    Principal Investigator

    Tongji Hosptial Affiliated to Tongji Medical College of Huazhong University fo Science and Technology